ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,807Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 2094

$1.25M Total Retail Price of All Prescriptions

Rank: 44 out of 2094

800 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 800 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 800 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 13,842 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 559 494 1 3
SIMVASTATIN 510 485 2 1
WARFARIN SODIUM 476 463 3 11
AMLODIPINE BESYLATE 441 414 4 2
METOPROLOL TARTRATE 402 370 5 10
HYDROCODONE-ACETAMINOPHEN 361 321 S3 6 42
FUROSEMIDE 332 312 7 6
LISINOPRIL 275 259 8 7
RAMIPRIL 250 208 9 48
HYDROCHLOROTHIAZIDE 240 225 10 12
POTASSIUM CHLORIDE 229 198 11 24
ATORVASTATIN CALCIUM 214 194 12 5
METFORMIN HCL 210 189 13 8
OMEPRAZOLE 208 194 14 4
SERTRALINE HCL 191 178 15 26
PRAVASTATIN SODIUM 191 166 15 18
ZOLPIDEM TARTRATE 188 174 17 14
FAMOTIDINE 176 156 18 34
FENTANYL 167 98 S2 19 68
TRICOR 153 101 20 99
DONEPEZIL HCL 150 148 21 20
METOPROLOL SUCCINATE 147 127 22 9
DIOVAN 145 133 23 13
JANUVIA 135 135 24 35
TAMSULOSIN HCL 133 131 25 29
ALENDRONATE SODIUM 128 124 26 30
PANTOPRAZOLE SODIUM 126 97 27 37
LYRICA 125 72 28 85
TRAMADOL HCL 125 113 28 33
CLOTRIMAZOLE-BETAMETHASONE 121 115 30 91
CYMBALTA 119 90 31 61
CITALOPRAM HBR 116 112 32 47
OXYCODONE-ACETAMINOPHEN 114 87 S2 33 40
NAMENDA 110 110 34 32
GABAPENTIN 107 89 35 23
CARBIDOPA-LEVODOPA 105 99 36 102
DIGOXIN 104 102 37 51
CARVEDILOL 103 96 38 19
ACTOS 98 76 39 112
CLOPIDOGREL 98 81 39 22
PAROXETINE HCL 98 71 39 77
LOVAZA 97 84 42 53
TORSEMIDE 96 60 43 118
NYSTATIN 90 87 44 167
PREDNISONE 88 74 45 54
GLIMEPIRIDE 86 85 46 31
NITROGLYCERIN PATCH 86 86 46 101
NOVOLOG 83 63 48 116
ADVAIR DISKUS 81 77 49 36
PLAVIX 81 70 49 38
SYNTHROID 81 71 49 44
RISPERIDONE 81 81 49 56
ESCITALOPRAM OXALATE 79 53 53 46
NIFEDIPINE ER 79 79 53 96
PROAIR HFA 78 59 55 45
CRESTOR 78 57 55 15
SINGULAIR 76 75 57 64
MIRTAZAPINE 75 65 58 43
LIDODERM 75 68 58 59
LANTUS 75 40 58 66
NEXIUM 74 57 61 16
LIPITOR 72 68 62 39
ENALAPRIL MALEATE 69 62 63 25
PRANDIN 68 64 64 125
TRAZODONE HCL 66 51 65 72
KLOR-CON M20 64 59 66 106
AZITHROMYCIN 63 56 67 27
ALPRAZOLAM 63 44 67 150
IPRATROPIUM-ALBUTEROL 63 59 67 92
ATENOLOL 63 62 67 21
CELEBREX 61 58 71 74
ALBUTEROL SULFATE 61 44 71 90
ISOSORBIDE MONONITRATE ER 61 49 71 57
NOVOLOG FLEXPEN 61 56 71 142
CIPROFLOXACIN HCL 58 50 75 81
DIOVAN HCT 57 56 76 28
VENLAFAXINE HCL ER 57 57 76 183
TRIAMCINOLONE ACETONIDE 55 55 78 186
CLONIDINE HCL 53 53 79 62
OXYCONTIN 52 25 S2 80 98
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 43 81 182
AMOX TR-POTASSIUM CLAVULANATE 50 38 82 107
SPIRONOLACTONE 50 38 82 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.